The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: Two new complementation groups of etoposide sensitive mutants

Mutation Research - DNA Repair

Volumn 435, Issue 3, 1999, Pages 271-282

  Johnson, Mark A ^a   Jones, Nigel J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adriamycin; Ataxia telangiectasia; DNA double strand breaks; Intragenic complementation; Topoisomerase inhibitors; XRCC genes

Indexed keywords

DACTINOMYCIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; DOUBLE STRANDED DNA; DOXORUBICIN; ETOPOSIDE; HYDROGEN PEROXIDE; MITOMYCIN C; OUABAIN; RUFOCROMOMYCIN; TIOGUANINE;

ANIMAL CELL; ARTICLE; ATAXIA TELANGIECTASIA; CELL FUSION; CHO CELL; CROSS ALLERGY; DRUG SENSITIVITY; GENE ISOLATION; GENE MUTATION; GENETIC COMPLEMENTATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CAMPTOTHECIN; CELL SEPARATION; CHO CELLS; CRICETINAE; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; ETOPOSIDE; GENETIC COMPLEMENTATION TEST; MITOMYCIN; MUTATION; NUCLEIC ACID HYBRIDIZATION; STREPTONIGRIN;

EID: 0032796408     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(99)00055-5     Document Type: Article

References (46)

1. Wang J.C. DNA topoisomerases. Annu. Rev. Biochem. 54:1985;665-697.
2. Austin C.A., Fisher L.M. DNA topoisomerases: enzymes that change the shape of DNA. Sci. Prog. 74:1990;147-162.
3. Heck M.M.S., Earnshaw W.C. Topoisomerase II: a specific marker for cell proliferation. J. Cell. Biol. 103:1986;2569-2581.
4. Shamu C.E., Murray A.W. Sister chromatid separation in frog egg extracts requires DNA topoisomerase II activity during anaphase. J. Cell Biol. 117:1992;921-934.
5. Di Nardo S., Voelkel K., Sternglanz R. DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc. Natl. Acad. Sci. USA. 81:1984;2616-2620.
6. Uemura T., Ohkura H., Adachi Y., Morino K., Shiozaki K., Yanagida M. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell. 50:1987;917-925.
7. Earshaw W.C., Halligan B.D., Cooke C.A., Heck M.S., Liu L.F. Topoisomerase II is a structural component of mitotic chromosome scaffolds. J. Cell. Biol. 100:1985;1706-1715.
8. Tan K.B., Dorman T.E., Falls K.M., Chung T.D.Y., Mirabelli C.K., Crooke S.T., Mao J. Topoisomerase II and topoisomerase II genes: characterization and mapping to human chromosome 17 and 3, respectively. Cancer Res. 52:1992;231-234.
9. Woessner R.D., Mattern M.R., Mirabelli C.K., Johnson R.K., Drake F.H. Proliferation and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH 3T3. Cell Growth Differ. 2:1991;209-214.
10. Osheroff N., Zechiedrich E.L., Gale K.C. Catalytic function of DNA topoisomerase II. Bioessays. 13:1991;269-275.
11. Ross W.E., Glaubiger D., Kohn K.W. Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochem. Biophys. Acta. 562:1979;41-50.
12. Zwelling L.A., Michaels S., Erickson L.C., Ungerleider R.S., Nichols M., Kohn K.W. Protein-associated DNA strand breaks in L1210 cells treated with the DNA intercalating agents m-AMSA and adriamycin. Biochemistry. 20:1981;6553-6563.
13. F.E. Durr, Biological and biochemical effects of mitozantrone, Seminars in Oncology II (Suppl.), 3-10.
14. Yang L., Rowe T.C., Nelson E.M., Liu L.F. In vivo mapping of DNA topoisomerase II-specific cleavage sites in SV40 chromatin. Cell. 41:1985;127-132.
15. Caldecott K., Banks G., Jeggo P. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II. Cancer Res. 50:1990;5778-5783.
16. Beall H.D., Liu Y., Siegel D., Bolton E.M., Gibson N.W., Ross D. Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin. Biochem. Pharmacol. 51:1996;645-652.
17. Yamashita Y., Kawada S.-Z., Fujii N., Nakano H. Induction of mammalain DNA topoisomerase II dependent DNA cleavage by antitumour antibiotic streptonigrin. Cancer Res. 50:1990;5841-5844.
18. G. Capranico, M. Palumbo, S. Tinelli, F. Zunino, Unique sequence specificity of topoisomerase II cleavage stimulation and DNA binding mode of streptonigrin, J. Biol. Chem. 269, 25004-25009.
19. Thompson L.H., Rubin J.S., Cleaver J.E., Whitmore G.F., Brookman K. A screening method for isolating DNA repair-deficient mutants of CHO cells. Somat. Cell Genet. 6:1980;391-405.
20. Jeggo P.A., Kemp L.M. X-ray-sensitive mutants of Chinese hamster ovary cell line. Isolation and cross-sensitivity to other DNA-damaging agents. Mutat. Res. 112:1983;313-327.
21. Jones N.J., Cox R., Thacker J. Isolation and cross-sensitivity of X-ray-sensitive mutants of V79-4 hamster cells. Mutat. Res. 183:1987;279-286.
22. Whitmore G.F., Varghese A.J., Gulyas S. Cell cycle responses of two X-ray sensitive mutants defective in DNA repair. Int. J. Radiat. Biol. 56:1989;657-665.
23. M.Z. Zdzienicka, J.W.I.M. Simons, Mutagen-sensitive lines are obtained with a high frequency in V79 Chinese hamster cell lines, Mutat. Res. 178, 235-244.
24. Thompson L.H., Jeggo P.A. Nomenclature of human genes involved in ionizing radiation sensitivity. Mutat. Res. 337:1995;131-134.
25. Collins A.R. Mutant rodent cell lines sensitive to ultraviolet light, ionizing radiation and cross-linking agents: a comprehensive survey of genetic and biochemical characteristics. Mutat. Res. 293:1993;99-118.
26. Robson C.N., Hoban P.R., Harris A.L., Hickson I.D. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines. Cancer Res. 47:1987;1560-1565.
27. Davies S.M., Robson C.N., Davies S.L., Hickson I.D. Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J. Biol. Chem. 263:1988;17724-17729.
28. Davies S.M., Davies S.L., Hall A.G., Hickson I.D. Isolation and partial characterization of a mammalian cell mutant hypersensitive to topoisomerase II inhibitors and X-rays. Mutat. Res. 235:1990;111-118.
29. Davies S.M., Davies S.L., Harris A.L., Hickson I.D. Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides. Cancer Res. 49:1989;4526-4530.
30. Giaccia A., Weinstein R., Hu J., Stamato T.D. Cell cycle-dependent repair of double-strand breaks in a X-ray-sensitive Chinese hamster cell. Somat. Cell. Mol. Genet. 11:1985;485-491.
31. Kemp L.M., Sedgwick S.G., Jeggo P.A. X-ray-sensitive mutants of Chinese hamster ovary cells defective in double-strand break rejoining. Mutat. Res. 132:1984;189-196.
32. M.Z. Zdienicka, Q. Tran, G.P. van der Schans, J.W.I.M. Simons, Characterization of an X-ray hypersensitive mutant of V79 Chinese hamster cell, Mutat. Res. (1988) 239-249.
33. Liu N., Lamerdin J.E., Tebbs R.S., Schild D., Tucker J.D., Shen M.R., Brookman K.W., Siciliano M.J., Walter C.A., Fan W., Narayana L.S., Zhou Z.-Q., Adamson A.W., Sorensen K.J., Chen D.J., Jones N.J., Thompson L.H. XRCC2 and XRCC3, new huamn Rad51-family members, promote chromosome stability and protect against DNA crosslinks and other damages. Mol. Cell. 1:1998;783-793.
34. North P.S., Davies S.L., Ciardiello F., Damiano V., Bianco C., Pepe S., Raffaele Bianco A., Harris A.L., Hickson I.D., Tortora G. Overexpression of the RI subunit of protein kinase A confers hypersensitivity to topoisomerase II inhibitors and 8-chloro-cyclic adenosine 3′-5′-monophosphate in Chinese hamster cells. Cancer Res. 54:1994;4123-4128.
35. Cho-Chung Y.S. Perspectives in cancer research: role of cAMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res. 50:1990;7093-7100.
36. Jones N.J., Cox R., Thacker J. Six complementation groups for ionising radiation sensitivity in Chinese hamster cells. Mutat. Res. 193:1988;139-144.
37. Thacker J., Ganesh A.N. DNA-break repair, radioresistance of DNA synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants: comparisons to ataxia telangiectasia cells. Mutat. Res. 235:1990;49-58.
38. Jeggo P.A., Caldecott K., Pidsley S., Banks G.R. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. Cancer Res. 49:1989;7057-7063.
39. Robson C.N., Hoban P.R., Harris A.L., Hickson I.D. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines. Cancer Res. 47:1987;1560-1565.
40. Jones N.J. Genetic analysis of mitomycin C hypersensitive Chinese hamster cell mutants. Mutagenesis. 9:1994;477-482.
41. CS components of the DNA-dependent protein kinase. Carcinogenesis. 19:1998;965-971.
42. Jones N.J., Ellard S., Waters R., Parry E.M. Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hmaster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanoni's anaemia cells. Carcinogenesis. 14:1993;2487-2494.
43. Zdzienicka M.Z., Jaspers N.G.J., van der Schans G.P., Natarajan A.T., Simons J.W.I.M. Ataxia-telangiectasia like Chinese hamster V79 cell mutants with radioresistant DNA synthesis, chromosomal instability, and normal DNA strand break repair. Cancer Res. 49:1989;1481-1485.
44. Jongmans W., Verhaegh G.W.C.T., Sankaranarayanan K., Lohman P.H.M., Zdzienicka M.Z. Cellular characteristics of Chinese hamster cell mutants resembling ataxia telangiectasia cells. Mutat. Res. 294:1993;207-214.
45. Garen A., Garen S. Complementation in vivo between structural mutants of alkaline phosphatase from E. coli. J. Mol. Biol. 7:1963;13-22.
46. Turner M.A., Simpson A., McInnes R.R., Howell P.L. Human arginosuccinate lyase: a structural basis for intragenic complementation. Proc. Natl. Acad. Sci. 94:1997;9063-9068.